Epidemiology of Parkinson’s Disease: An Update

Deliz, Juan R; Tanner, Caroline M.; Gonzalez-Latapi, Paulina

doi:10.1007/s11910-024-01339-w

Curr Neurol Neurosci Rep

2024

DOI: 10.1007/s11910-024-01339-w

|View full text |Cite

Epidemiology of Parkinson’s Disease: An Update

Juan R Deliz,

Caroline M. Tanner,

Paulina Gonzalez-Latapi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 188 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease

Guedi,

Ikram,

Youssef

et al. 2024

J Neural Transm

View full text Add to dashboard Cite

Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease

Guedi,

Ikram,

Youssef

et al. 2024

J Neural Transm

View full text Add to dashboard Cite

Grey matter volume differences across Parkinson’s disease motor subtypes in the supplementary motor cortex

Martin,

Nassif,

Chaluvadi

et al. 2025

NeuroImage: Clinical

View full text Add to dashboard Cite

Deep Brain Stimulation Impairment Scale in Brazilian Portuguese: Cross-cultural adaptation and content validity

Tauil,

Hamdan

2024

J Health Psychol

View full text Add to dashboard Cite

Parkinson’s disease has exhibited the most rapid increase in prevalence among neurodegenerative disorders over the past 25 years. With the expanding availability of its surgical interventions and the controversial side effects identified in the literature, it is urgent to develop instruments for discerning subtle changes in patients’ biopsychosocial functioning. Therefore, the primary objective of this study was to culturally adapt the Deep Brain Stimulation Impairment Scale (DBS-IS) into Brazilian Portuguese and evaluate its content validity. The final version of the DBS-IS in Brazilian Portuguese comprises 19 Likert items and yielded an S-CVI of 0.97, indicating robust content validity. Given the escalating number of Parkinson’s disease diagnoses annually in Brazil, this tool may prove beneficial for practitioners and could also contribute to clarifying some of the apparent disparities among users of brain stimulation therapies worldwide and in Brazil.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Epidemiology of Parkinson’s Disease: An Update

Cited by 6 publications

References 188 publications

Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease

Glutathione S-transferase polymorphisms (GSTM1/GSTT1) outcomes in clinical profile and treatment responsiveness among Tunisian cohort of Parkinson’s disease

Grey matter volume differences across Parkinson’s disease motor subtypes in the supplementary motor cortex

Deep Brain Stimulation Impairment Scale in Brazilian Portuguese: Cross-cultural adaptation and content validity

Contact Info

Product

Resources

About